{"id":171926,"date":"2025-12-03T00:09:06","date_gmt":"2025-12-03T00:09:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/171926\/"},"modified":"2025-12-03T00:09:06","modified_gmt":"2025-12-03T00:09:06","slug":"more-fda-drama-top-drug-regulator-calls-it-quits-after-3-weeks","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/171926\/","title":{"rendered":"More FDA drama: Top drug regulator calls it quits after 3 weeks"},"content":{"rendered":"

The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three weeks after taking the leading position, according to multiple media outlets.<\/p>\n

Pazdur, an oncologist who has worked at the FDA since 1999, was seen as a stabilizing force for an agency that has been mired in turmoil during the second Trump administration. He took over the role of leading the FDA\u2019s Center for Drug Evaluation and Research on November 11, after the previous leader, George Tidmarsh, left the agency amid an investigation and a lawsuit regarding allegations that he used his position to exact petty revenge<\/a> on a former business partner. In light of the scandal, one venture capital investor called the agency a \u201cclown show<\/a>.\u201d Drug industry groups, meanwhile, called the FDA erratic and unpredictable<\/a>.<\/p>\n

Pazdur\u2019s selection was seen as a positive sign by agency insiders, drug industry representatives, and patient advocacy groups, according to reporting by The Washington Post<\/a>.<\/p>\n

But things quickly soured. Just days on the job, Pazdur expressed deep concerns about the legality and public health risks<\/a> of FDA Commissioner Marty Makary\u2019s plans to overhaul and expedite agency operations. On November 21, the Post reported that Pazdur disagreed with Makary\u2019s plans to reduce the number of studies needed to make drug-related decisions, such as label changes. Pazdur was further concerned that Makary\u2019s plan to shorten drug review times was not sufficiently transparent and could be illegal. Pazdur also pushed back on Makary\u2019s plan to exclude agency career scientists from some drug review processes deemed political priorities.<\/p>\n","protected":false},"excerpt":{"rendered":"The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the…\n","protected":false},"author":2,"featured_media":171927,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[103,61,60,371],"class_list":{"0":"post-171926","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-ie","10":"tag-ireland","11":"tag-medication"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/171926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=171926"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/171926\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/171927"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=171926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=171926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=171926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}